Affymax

NCT00109291

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

NCT00228449

Peginesatide for Anemia in Chronic Hemodialysis Patients

NCT00228436

Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

NCT00272662

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

NCT00372489

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

NCT00453973

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

NCT00434330

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

NCT00680043

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

NCT00752609

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

NCT00752791

Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.